{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_4092", "batch_size": 260, "batch_pos": 56, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment uses neutral language ('too early to tell', 'be able to manufacture', 'said') lacking high-potency framing.", "method": "llm_batch", "batch_id": "batch_2_16288", "batch_size": 260, "batch_pos": 18, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment states it is too early to tell how many doses can be manufactured, lacking moderate verbs + scale/impact.", "method": "llm_batch", "batch_id": "batch_3_6120", "batch_size": 260, "batch_pos": 223, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_15088", "batch_size": 260, "batch_pos": 185, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "This segment reports uncertainty and contains no explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_10548", "batch_size": 260, "batch_pos": 182, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No minimiser + scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_15988", "batch_size": 260, "batch_pos": 149, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_18092", "batch_size": 260, "batch_pos": 141, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "no", "rationale": "Statement about uncertainty regarding future manufacturing capability, not capability or preparedness.", "method": "llm_batch", "batch_id": "batch_8_12120", "batch_size": 260, "batch_pos": 237, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 9, "answer": "no", "rationale": "The segment discusses uncertainty about manufacturing capacity, not factual reporting of prices or metrics.", "method": "llm_batch", "batch_id": "batch_9_17220", "batch_size": 260, "batch_pos": 152, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 10, "answer": "no", "rationale": "The segment states that it is currently too early to tell about manufacturing capacity, not speculation about future relief.", "method": "llm_batch", "batch_id": "batch_10_14860", "batch_size": 260, "batch_pos": 241, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 11, "answer": "no", "rationale": "Attributed statement is about manufacturing capacity, not framing risk/safety.", "method": "llm_batch", "batch_id": "batch_11_18092", "batch_size": 260, "batch_pos": 234, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
